Pictured: Michael Berger
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, June 12, 2014

A powerful diagnostic test, MSK-IMPACT™ gives our doctors an unparalleled amount of information about individual people’s cancers to guide their treatment.

Pictured: Activated macrophage
In the Lab
By Jennifer Bell, PhD  |  Thursday, June 5, 2014

Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: 2014 Graduates
Event
By Julie Grisham, MS, Science Writer/Editor  |  Friday, May 23, 2014

Degrees were presented and awards were given at the 35th annual ceremony held on May 14.

Pictured: Tari King
In the News
By Jennifer Bassett, MA, Senior Managing Editor & Content Strategist  |  Thursday, May 22, 2014

Memorial Sloan Kettering breast surgeon Tari King talks to CBS Online about a new study suggesting double mastectomies may be performed unnecessarily in many women.

Pictured: Mark Kris
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, May 21, 2014

A new study has found that driver mutations can be found in about two-thirds of lung adenocarcinomas, suggesting options for treatment with targeted therapies.

Pictured: José Baselga, Agnès Viale,  Michael Berger & David Solit
Announcement
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 20, 2014

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

pictured: Martin S. Tallman
Profile
By Maureen Salamon, BA, Freelance Writer  |  Monday, May 19, 2014

Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

Pictured: Liver Cells
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Friday, May 16, 2014

Cell biologist Michael Overholtzer explains apoptosis, a form of programmed cell death that can lead to cancer when it doesn’t function properly.

Pictured: Jason Lewis, Anna-Katerina Hadjantonakis & Daniel Heller
Announcement
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, May 12, 2014

The new center brings together scientists and clinicians working in various fields who will use the power of imaging to speed research and innovations in cancer care.

Pictured: Jedd Wolchok
In the News
By Jim Stallard, MA, Writer/Editor  |  Friday, May 2, 2014

Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American.

Pictured: Macrophage & Tumor Cells
Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, May 1, 2014

Approaches used for research into the social lives of bacteria can also be used to explore how tumors behave and evolve.

Pictured: Michelle Bradbury
Q&A
By Jim Stallard, MA, Writer/Editor  |  Thursday, April 24, 2014

A new optical-imaging approach could enable surgeons to more precisely visualize cancerous tissue during an operation.